Product Wiki · Recalls · Health Canada — Medical Devices

Hemosil Readiplastin (20 mL Size) — recall 57428

Health Canada — Medical Devices · Canada · 2022-05-13 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →

Agency: Health Canada — Medical Devices
Recall identifier: 57428
Date of alert: 2022-05-13
Country / jurisdiction: Canada
Risk level: Type II
Risk type: recall
Product category: Haematology
Product type: Medical devices
Notice status: Archived by the issuing authority — kept for reference

Reported risk: We recently received customer reports of performance issues with some vials of hemosil readiplastin PN 0020301400 Lot No, N0705526, including increased imprecision, out of range quality controls and prolonged sample results. Recall start date: Oct. 13, 2021

Primary source: https://recalls-rappels.canada.ca/en/alert-recall/hemosil-readiplastin-20-ml-siz

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

Hemosil Readiplastin (20 mL Size) — recall 57428

Related